209 related articles for article (PubMed ID: 29305065)
21. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages.
Jiang C; Yuan F; Wang J; Wu L
Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495
[TBL] [Abstract][Full Text] [Related]
22. PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density.
Tamburini BAJ; Elder AM; Finlon JM; Winter AB; Wessells VM; Borges VF; Lyons TR
Front Immunol; 2019; 10():1313. PubMed ID: 31244852
[TBL] [Abstract][Full Text] [Related]
23. Carboplatin and programmed death-ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model.
Zhu X; Xu J; Cai H; Lang J
J Obstet Gynaecol Res; 2018 Feb; 44(2):303-311. PubMed ID: 29171115
[TBL] [Abstract][Full Text] [Related]
24. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
[TBL] [Abstract][Full Text] [Related]
25. Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.
Bracamonte-Baran W; Florentin J; Zhou Y; Jankowska-Gan E; Haynes WJ; Zhong W; Brennan TV; Dutta P; Claas FH; van Rood JJ; Burlingham WJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1099-1104. PubMed ID: 28096390
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma.
Hatogai K; Kitano S; Fujii S; Kojima T; Daiko H; Nomura S; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A
Oncotarget; 2016 Jul; 7(30):47252-47264. PubMed ID: 27322149
[TBL] [Abstract][Full Text] [Related]
27. Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.
Suleman M; Cyprian FS; Jimbo S; Maina T; Prysliak T; Windeyer C; Perez-Casal J
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311234
[No Abstract] [Full Text] [Related]
28. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Aslan K; Turco V; Blobner J; Sonner JK; Liuzzi AR; Núñez NG; De Feo D; Kickingereder P; Fischer M; Green E; Sadik A; Friedrich M; Sanghvi K; Kilian M; Cichon F; Wolf L; Jähne K; von Landenberg A; Bunse L; Sahm F; Schrimpf D; Meyer J; Alexander A; Brugnara G; Röth R; Pfleiderer K; Niesler B; von Deimling A; Opitz C; Breckwoldt MO; Heiland S; Bendszus M; Wick W; Becher B; Platten M
Nat Commun; 2020 Feb; 11(1):931. PubMed ID: 32071302
[TBL] [Abstract][Full Text] [Related]
29. PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
Shi X; Zhang X; Li J; Mo L; Zhao H; Zhu Y; Hu Z; Gao J; Tan W
Int J Cancer; 2018 May; 142(10):2106-2117. PubMed ID: 29243219
[TBL] [Abstract][Full Text] [Related]
30. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
[TBL] [Abstract][Full Text] [Related]
31. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface.
Meggyes M; Miko E; Szigeti B; Farkas N; Szereday L
BMC Pregnancy Childbirth; 2019 Feb; 19(1):74. PubMed ID: 30782114
[TBL] [Abstract][Full Text] [Related]
32. The helminth-derived peptide GK-1 induces an anti-tumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway.
Rodríguez-Rodríguez N; Madera-Salcedo IK; Bugarin-Estrada E; Sánchez-Miranda E; Torres-García D; Cervantes-Torres J; Fragoso G; Rosetti F; Crispín JC; Sciutto E
Clin Immunol; 2020 Mar; 212():108240. PubMed ID: 31299381
[TBL] [Abstract][Full Text] [Related]
33. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
Che YM; Zhang Y; Li M; Li XP; Zhang LL
J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal T lymphocyte regulation by macrophages.
Composto G; Gonzalez D; Bucknum A; Silberman D; Taylor J; Kozlowski M; Bloomfield T; Bartlett T; Riggs J
Immunobiology; 2011; 216(1-2):256-64. PubMed ID: 20488579
[TBL] [Abstract][Full Text] [Related]
37. The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.
Li HY; McSharry M; Bullock B; Nguyen TT; Kwak J; Poczobutt JM; Sippel TR; Heasley LE; Weiser-Evans MC; Clambey ET; Nemenoff RA
Cancer Immunol Res; 2017 Sep; 5(9):767-777. PubMed ID: 28819064
[TBL] [Abstract][Full Text] [Related]
38. Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
Arina A; Karrison T; Galka E; Schreiber K; Weichselbaum RR; Schreiber H
Cancer Immunol Res; 2017 Feb; 5(2):127-136. PubMed ID: 28077434
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
Zhang Y; Du W; Chen Z; Xiang C
Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
[TBL] [Abstract][Full Text] [Related]
40. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.
Huang J; Wang X; Li B; Shen S; Wang R; Tao H; Hu J; Yu J; Jiang H; Chen K; Luo C; Dang Y; Zhang Y
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
